NUVOLA, GIACOMO

NUVOLA, GIACOMO  

Borsisti  

Mostra records
Risultati 1 - 20 di 22 (tempo di esecuzione: 0.03 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy Marchese, Paola Valeria; Mollica, Veronica; De Biase, Dario; Giunchi, Francesca; Tassinari, Elisa...; Marchetti, Andrea; Rosellini, Matteo; Nuvola, Giacomo; Maloberti, Thais; Fiorentino, Michelangelo; Massari, Francesco 2022-01-01 PATHOLOGY RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study Rizzo A.; Mollica V.; Marchetti A.; Nuvola G.; Rosellini M.; Tassinari E.; Molina-Cerrillo J.; My...int Z.W.; Buchler T.; Monteiro F.S.M.; Grande E.; Santoni M.; Massari F. 2022-01-01 CANCERS - 1.01 Articolo in rivista -
An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt Mollica V.; Marchetti A.; Rosellini M.; Nuvola G.; Rizzo A.; Santoni M.; Cimadamore A.; Montironi... R.; Massari F. 2021-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista -
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo,... Alessandro; Massari, Francesco; Mollica, Veronica 2023-01-01 EXPERT OPINION ON DRUG SAFETY - 1.01 Articolo in rivista -
Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw Mollica V.; Nuvola G.; Tassinari E.; Nigro M.C.; Marchetti A.; Rosellini M.; Rizzo A.; Errani C.;... Massari F. 2022-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista -
Carboplatin, nab-paclitaxel plus atezolizumab in Impower 130 trial: New weapons beyond controversies de Giglio A.; Nuvola G.; Gustavo Dall'Olio F. 2019-01-01 TRANSLATIONAL CANCER RESEARCH - 1.01 Articolo in rivista -
Cardiac Toxicity From Afatinib in EGFR-Mutated NSCLC: A Rare But Possible Side Effect Nuvola G.; Dall'Olio F.G.; Melotti B.; Sperandi F.; Ardizzoni A. 2019-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Clinical consideration for choosing combination therapies in advanced non-small-cell lung cancer: Age, Eastern Cooperative Organization performance status 2, steroids and antibiotics de Giglio A.; Nuvola G.; Baldini C. 2020-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases Di Nunno Vincenzo; Nuvola Giacomo; Mosca Mirta; Maggio Ilaria; Gatto Lidia; Tosoni Alicia; Lodi R...affaele; Franceschi Enrico; Brandes Alba Ariela 2021-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience Dall'Olio F.G.; Conci N.; Rossi G.; Fiorentino M.; De Giglio A.; Grilli G.; Altimari A.; Gruppion...i E.; Filippini D.M.; Di Federico A.; Nuvola G.; Ardizzoni A. 2020-01-01 LUNG CANCER - 1.01 Articolo in rivista -
Development and Management of Massive Subcutaneous Metastases with Unusual Clinical Course from Uterine Leiomyosarcoma DM, Filippini; G, Nuvola; M, Nannini; M, Saponara; S, Cammelli; Paolis M, De; AM, Perrone; Iaco P..., De; Leo A, De; A, Astolfi; MA, Pantaleo 2021-01-01 Journal of Cancer Science and Clinical Therapeutics - 1.01 Articolo in rivista -
Guiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer Rosellini M.; Marchetti A.; Tassinari E.; Nuvola G.; Rizzo A.; Santoni M.; Mollica V.; Massari F. 2022-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista -
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? Di Federico A.; Nuvola G.; Sisi M.; Lenzi B.; Nobili E.; Campana D. 2020-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis Rizzo, Alessandro; Nuvola, Giacomo; Palmiotti, Gennaro; Ahcene-Djaballah, Selma; Mollica, Veronic...a; Rosellini, Matteo; Marchetti, Andrea; Nigro, Maria Concetta; Tassinari, Elisa; Macrini, Sveva; Massari, Francesco 2023-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
IMpower 132: Is the Second Exception to the Rule No Longer an Exception? Di Federico A.; Nuvola G.; Deiana C.; Donati G.; De Giglio A. 2021-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis Di Federico A.; De Giglio A.; Nuvola G.; Deiana C.; Conci N.; Gelsomino F.; Ardizzoni A. 2021-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis Mollica V.; Massari F.; Andrini E.; Rosellini M.; Marchetti A.; Nuvola G.; Tassinari E.; Lamberti... G.; Campana D. 2022-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista -
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution Di Federico A.; Andrini E.; Sisi M.; Nuvola G.; Lamberti G.; Lenzi B.; Nobili E.; Gelsomino F.; A...rdizzoni A. 2021-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
The dilemma of neoadjuvant and adjuvant therapy in urothelial carcinoma: Will immunotherapy solve the problem? Nuvola G.; Rizzo A.; Mollica V.; Massari F. 2022-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines) De Giglio A.; Di Federico A.; Nuvola G.; Deiana C.; Gelsomino F. 2021-01-01 CURRENT ONCOLOGY REPORTS - 1.01 Articolo in rivista -